Evaluation of a Chemoresponse Assay as a Predictive Marker in the Treatment of Recurrent Ovarian Cancer: Further Analysis of a Prospective Study

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2014.375
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Circulating Tumor Cells Enumerated by a Centrifugal Microfluidic Device as a Predictive Marker for Monitoring Ovarian Cancer Treatment: A Pilot Study

Diagnostics
Clinical Biochemistry
2020English

Circulating Tumor Cells as a Prognostic and Predictive Marker in Gastrointestinal Stromal Tumors: A Prospective Study

Oncotarget
Oncology
2016English

Tumor Endothelial ELTD1 as a Predictive Marker for Treatment of Renal Cancer Patients With Sunitinib

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

PET Scans as a Predictive Marker of Survival in Advanced Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2015English

Sialyl Tn as a Prognostic Marker in Epithelial Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1992English

Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer

PLoS ONE
Multidisciplinary
2009English

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

Journal of Cancer
Oncology
2017English

Napsin a as a Marker of Clear Cell Ovarian Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

A Prospective Study of Macrophage Migration Inhibitory Factor as a Marker of Inflammatory Detection

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy